Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Anti-Meth Draft Places PSE Behind Counter, Lacks Schedule V Language

This article was originally published in The Tan Sheet

Executive Summary

Current draft report language in the Patriot Act places all pseudoephedrine products behind the counter but does not contain a Schedule V provision, according to the Consumer Healthcare Products Association
Advertisement

Related Content

CHPA Year In Review: Legislative Accomplishments, OTC Product Awareness And Goals For 2006
Patriot Act and PSE
Patriot Act and PSE
Patriot Act and PSE
Pseudoephedrine Sales Limit Provisions Attached To Patriot Act
Pseudoephedrine Sales Limit Provisions Attached To Patriot Act
Pseudoephedrine Behind-The-Counter Limit Sought By Meth Fighting Senators

Topics

Advertisement
UsernamePublicRestriction

Register

PS098861

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel